Autolus Therapeutics Receives FDA Orphan Drug Designation for AU
AUTL: Autolus Therapeutics plc
2019-11-05 09:10:33
Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia
2019-11-05 09:10:33
Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia